Dog Autoimmune Hemolytic Anemia: Crisis Management

Immune-mediated hemolytic anemia is a life-threatening emergency requiring rapid intervention, but with appropriate treatment many dogs achieve full remission.

Key Facts

Immune-mediated hemolytic anemia (IMHA) involves immune destruction of red blood cells
It can be primary (idiopathic) or secondary to infection, drugs, or cancer
Affected dogs present with sudden severe weakness, pale or yellow gums, rapid breathing, and collapse
Without treatment, IMHA can be fatal within hours to days from profound anemia
Treatment includes immunosuppressive doses of prednisolone, often with azathioprine or mycophenolate
Blood transfusion is lifesaving in severe cases but is complicated by the ongoing immune destruction of transfused cells

Welfare Considerations

IMHA causes acute welfare harm through severe anemia-induced hypoxia - tissues starved of oxygen cause weakness, confusion, rapid heart rate, and respiratory distress. Dogs in IMHA crisis are truly critically ill, experiencing symptoms equivalent to severe blood loss. The condition can deteriorate from mild lethargy to collapse and death within 24 hours if untreated. Emergency treatment - immunosuppression to stop red blood cell destruction and blood transfusion to maintain oxygen delivery - saves lives and dramatically reduces suffering duration. Thromboembolism is a significant complication requiring concurrent prophylactic treatment. The welfare burden of IMHA treatment (hospital stays, repeated blood tests, immunosuppressive side effects) is substantial, but the alternative without treatment is rapid death.

What You Can Do

Seek emergency veterinary care immediately for any dog showing sudden weakness, pale gums, or rapid breathing
Authorize blood transfusion if recommended - it is often lifesaving in severe IMHA
Start immunosuppressive therapy promptly as directed by your veterinarian
Ask about thromboembolism prevention - it is a serious and often fatal complication of IMHA
Monitor for relapse during drug tapering - IMHA can recur when immunosuppression is reduced
Investigate for underlying causes (infection, drugs, cancer) in all IMHA cases